By Professor Ric Day

Book Chapters

Yu SP; Day RO, 2023, 'Chapter 8 Pharmacotherapy', in Osteoarthritis Health Professional Training Manual, Elsevier, pp. 125 - 145, http://dx.doi.org/10.1016/b978-0-323-99269-5.00006-2

Yu SP; Day RO, 2022, 'Pharmacotherapy', in Osteoarthritis Health Professional Training Manual, pp. 125 - 145, http://dx.doi.org/10.1016/B978-0-323-99269-5.00006-2

Pile KD; Graham GG; Mahler SM; Day RO, 2019, 'Disease-Modifying Anti-rheumatic Drugs', in Nijkamp and Parnham’s Principles of Immunopharmacology: Fourth revised and extended edition, pp. 709 - 750, http://dx.doi.org/10.1007/978-3-030-10811-3_34

Baysari M; Chan J; Carland J; Stocker S; Moran M; Day R, 2018, 'Usability of Reports Generated by a Computerised Dose Prediction Software', in Connecting the System to Enhance the Practitioner and Consumer Experience in Healthcare, IOS Press, pp. 27 - 32, http://dx.doi.org/10.3233/978-1-61499-890-7-27

Day R; pile KD; graham GG; katelaris C, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7

Day R; graham GG, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1 - 7, http://dx.doi.org/10.1007/978-3-0348-0620-6_22-1

Graham GG; Roberts MS; Day RO; Rainsford KD, 2016, 'Pharmacokinetics and metabolism of the salicylates', in Aspirin and Related Drugs, pp. 97 - 155

Pile KD; Graham GG; Katelaris CH; Day RO, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7_9

Graham GG; Day RO, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 383 - 389, http://dx.doi.org/10.1007/978-3-7643-8550-7_22

Day RO; Graham GG, 2016, 'Non-steroidal Anti-inflammatory Drugs: Overview', in Compendium of Inflammatory Diseases, Springer Basel, pp. 986 - 993, http://dx.doi.org/10.1007/978-3-7643-8550-7_52

Day RO; Graham GG; Williams K, 2016, 'Propionic Acid Derivative Drugs (Profens)', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1106 - 1110, http://dx.doi.org/10.1007/978-3-7643-8550-7_58

Day RO; Graham GG; Williams K, 2016, 'Propionic Acid Derivative Drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer Basel, pp. 1 - 6, http://dx.doi.org/10.1007/978-3-0348-0620-6_58-4

Graham GG; Day RO, 2016, 'Salicylates', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1169 - 1174, http://dx.doi.org/10.1007/978-3-7643-8550-7_62

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Dalbeth N; Peresa-Ruiz F; Schlesinger N (ed.), Gout, Future Medicine Ltd, pp. 174 - 188, http://dx.doi.org/10.2217/ebo.13.104

Pile K; Graham GG; Katelaris CH; Day RO, 2013, 'Antimalarial Drugs', in Encyclopedia of Inflammatory Diseases, Springer Basel, pp. 1 - 6, http://dx.doi.org/10.1007/978-3-0348-0620-6_9-1

Day RO; Graham GG, 2013, 'Non-steroidal Anti-inflammatory Drugs', in Encyclopedia of Inflammatory Diseases, Springer Basel, pp. 1 - 9, http://dx.doi.org/10.1007/978-3-0348-0620-6_52-2

Graham GG; Day RO, 2013, 'NSAIDs and Their Indications', in Encyclopedia of Pain, Springer Berlin Heidelberg, pp. 2317 - 2322, http://dx.doi.org/10.1007/978-3-642-28753-4_2847

Pile KD; Graham GG; Mahler SM; Day RO, 2011, 'C15 Disease-modifying antirheumatic drugs', in Principles of Immunopharmacology, Birkhäuser Basel, pp. 585 - 619, http://dx.doi.org/10.1007/978-3-0346-0136-8_30

Pile K; Graham GG; Mahler SM; Day RO, 2011, 'Disease modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 585 - 619, http://books.google.com.au/books?id=X0deXiGtcCAC&printsec=frontcover#v=onepage&q&f=false

Baysari MT; Westbrook J; Day RO, 2011, 'Medication decision-making on hospital ward-rounds', in Moen A; Andersen SK; Aarts J; Hurlen P (ed.), Studies in Health Technology and Informatics, IOS Press, Amsterdam, pp. 935 - 939, http://dx.doi.org/10.3233/978-1-60750-806-9-935

Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), Birkhauser Verlag, Basel, pp. 511 - 544

Day RO, 2003, 'Therapy of osteoarthritis', in Scott D; Cope A (ed.), The Year in Rheumatic Disorders 2003, Clinical Publishibg Services Ltd, Oxford, United Kingdom, pp. 23 - 34

Day RO; Quinn DE; Williams KK; Handel ML; Brooks PM, 2000, 'Connective tissue and bone disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, McGrath Hill, New York, pp. 645 - 702

Day RO, 2000, 'Rheumatic Disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, McGrath Hill, New York, pp. 645 - 702

Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, Oxford University Press, Oxford, England, pp. 307 - 328

Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, Blackwell Science, Oxford, UK, pp. 174 - 189

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403

Brooks PM; Savdie E; Day RO, 1998, 'Antirheumatic drugs and renal disease', in Rheumatology (2nd Ed), Gower, London, pp. 28 - 29

Brooks PM; Day RO, 1998, 'Arthritis', in Drug Therapy in old age, Wiley & Sons, Chichester UK, pp. 387 - 400

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1998, 'Disease Modifying antirheumatic drugs', in Textbook of Immunopharmacology, Burkhauser, Basel, Switzerland

Day RO, 1998, 'Formulary and Guide to Prescribing (second edition)', in Formulary Guide to Prescribing (2nd Ed), St. Vincent's Hospital, Sydney, Australia, pp. 1 - 445

Yeomans N; Brooks PM; Day RO, 1998, 'Non steroidal anti-inflammatory drugs and peptic ulceration', in Rheumatology (2nd Ed), Gower, London, pp. 27 - 28

Day RO, 1998, 'SARDS', in Rheumatology (2nd Ed), Gower, London, pp. 8.1 - 8.10

Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht

Quinn DE; Day RO, 1997, 'Guide to Clinically More Important Drug Interactions.', in Drug Safety, Adis International Limited, Auckland, New Zealand, pp. 1665 - 1700

Day RO, 1997, 'Sulfasalazine.', in In: `The Textbook of Rheumatology`, Edition 5., pp. 741 - 746

Graham GG; Milligan MK; Day RO; Williams KM; Zeig , 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, Kluwer Academic Publishers, Great Britain, pp. 77 - 92

Day RO; Graham GG, 'NSAIDs and their Indications', in Encyclopedia of Pain, Springer Berlin Heidelberg, pp. 1460 - 1463, http://dx.doi.org/10.1007/978-3-540-29805-2_2847

Journal articles

Ferdiana A; Mashuri YA; Wulandari LPL; Rahayu ID; Hasanah M; Ayuningsih Z; Batura N; Khan M; Liverani M; Guy R; Schierhout G; Kaldor J; Law M; Day R; Jan S; Wibawa T; Probandari A; Yeung S; Wiseman V, 2024, 'The impact of a multi-faceted intervention on non-prescription dispensing of antibiotics by urban community pharmacies in Indonesia: a mixed methods evaluation', BMJ Global Health, 9, http://dx.doi.org/10.1136/bmjgh-2024-015620

Shen I; Stojanova J; Yeo M; Olsen N; Lockart I; Wang M; Roggeveld J; Heerspink HJL; Greenfield JR; Day R; Danta M, 2024, 'A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease', British Journal of Clinical Pharmacology, 90, pp. 2529 - 2538, http://dx.doi.org/10.1111/bcp.16139

Carland JE; Carland DJ; Brett J; Stocker SL; Roberts DM; Day RO; Laba TL, 2024, 'Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic review', British Journal of Clinical Pharmacology, 90, pp. 2038 - 2066, http://dx.doi.org/10.1111/bcp.16164

Schulz M; Day RO; Coleshill MJ; Briggs NE; Aung E, 2024, 'Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout', Clinical Rheumatology, 43, pp. 2943 - 2954, http://dx.doi.org/10.1007/s10067-024-07050-y

Wabe N; Huang G; Silva SM; Nguyen AD; Seaman K; Raban MZ; Gates P; Day R; Close JCT; Lord SR; Westbrook JI, 2024, 'A Longitudinal Study of the Use and Effects of Fall-Risk-Increasing Drugs in Residential Aged Care', Journal of the American Medical Directors Association, 25, http://dx.doi.org/10.1016/j.jamda.2024.105074

Kirubakaran R; Singh RM; Carland JE; Day RO; Stocker SL, 2024, 'Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients', Therapeutic Drug Monitoring, 46, pp. 434 - 445, http://dx.doi.org/10.1097/FTD.0000000000001210

Mumford V; Raban MZ; Li L; Fitzpatrick E; Woods A; Merchant A; Badgery-Parker T; Gates P; Baysari M; Day RO; Ambler G; Dalla-Pozza L; Gazarian M; Gardo A; Barclay P; White L; Westbrook JI, 2024, 'Developing a process to measure actual harm from medication errors in paediatric inpatients: From design to implementation', British Journal of Clinical Pharmacology, 90, pp. 1615 - 1626, http://dx.doi.org/10.1111/bcp.16052

de Oliveira Costa J; Lin J; Milder TY; Greenfield JR; Day RO; Stocker SL; Neuen BL; Havard A; Pearson SA; Falster MO, 2024, 'Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia', Diabetes, Obesity and Metabolism, 26, pp. 2787 - 2795, http://dx.doi.org/10.1111/dom.15597

Selvadurai D; Coleshill MJ; Day RO; Briggs NE; Schulz M; Reath J; Aung E, 2024, 'Patient factors and health outcomes associated with illness perceptions in people with gout', Rheumatology (United Kingdom), 63, pp. 1927 - 1937, http://dx.doi.org/10.1093/rheumatology/kead501

Back to profile page